Table 1.
AGREE II domain scores of the included CGs on the management of headache in children
|
Guideline reference |
Year |
Diagnosis and/or treatment |
Population |
Domain 1 |
Domain 2 |
Domain 3 |
Domain 4 |
Domain 5 |
Domain 6 |
Overall quality score (range 1-7) (M ± SD) |
Overall assessment usage recommendations (n = 11)* |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope and purpose % | Stakeholder involvement % | Rigor of development % | Clarity and presentation % | Applicability % | Editorial indipendence % | ||||||
| Lewis
[21] |
2002 |
Diagnosis |
Children and adolescents |
82.3 |
53 |
72.9 |
82.8 |
48.9 |
53 |
5.45 ± 1.13 |
SR = 8 (72.7%); R = 2 (18.2%) NR = 1 (9.1%) |
| SISC
[22] |
2003 |
Diagnosis and treatment |
Children and adolescents |
67.2 |
81.3 |
57.8 |
64.1 |
43.6 |
41.7 |
4.73 ± 1.49 |
SR = 3 (27.3%); R =5 (45.4%) NR = 3 (27.3%) |
| Lewis
[23] |
2004 |
Treatment |
Children and adolescents |
79.8 |
49 |
68.4 |
77.3 |
44.7 |
61.4 |
5.36 ± 0.81 |
SR = 5 (45.4%); R = 6 (54.6%) |
| Geraud
[24] |
2004 |
Diagnosis and treatment |
Adult and children |
60.6 |
55 |
42.8 |
67.2 |
31.4 |
56.8 |
4.18 ± 1.08 |
SR = 1 (9.1%); R = 5 (45.4%) NR = 5 (45.4%) |
| Bendtsen
[25] |
2012 |
Diagnosis and treatment |
Adult and children |
62.6 |
56.1 |
37.5 |
65.7 |
36 |
68.9 |
4.18 ± 1.54 |
SR =5 (45.4%); R =1 (9.1%) NR = 5 (45.4%) |
| NICE [26] | 2012 | Diagnosis and treatment | Adult and young people | 92.9 | 86.4 | 90.7 | 94.9 | 75.4 | 74.2 | 6.54 ± 0.69 | SR = 8 (72.7%); R = 3 (27.3%) |
AGREE = Appraisal of Guidelines for Research and Evaluation; CGs = Clinical Guidelines.
SR = Strongly recommended; R = Recommended with modification; NR = Not recommended.
*number of pediatrics included in the study.